ArriVent BioPharma (AVBP) Files $250M Mixed Shelf
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Join SI Premium – FREE
ArriVent BioPharma (NASDAQ: AVBP) has filed $250,000,000 mixed shelf of:
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
RIGHTS
UNITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- Avalo Therapeutics adds Ron Philip to its board of directors
- Creatd files Form S-1 and reports Q1 2026 financial results
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
